Vaughan Nelson Investment Management L.P. Purchases 35,435 Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Vaughan Nelson Investment Management L.P. lifted its position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 4.8% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 768,940 shares of the company’s stock after buying an additional 35,435 shares during the quarter. Vaughan Nelson Investment Management L.P. owned approximately 0.83% of Acadia Healthcare worth $48,758,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently made changes to their positions in ACHC. GAMMA Investing LLC lifted its position in shares of Acadia Healthcare by 57.1% in the 3rd quarter. GAMMA Investing LLC now owns 663 shares of the company’s stock worth $42,000 after purchasing an additional 241 shares during the period. Blue Trust Inc. increased its holdings in shares of Acadia Healthcare by 86.1% in the 2nd quarter. Blue Trust Inc. now owns 536 shares of the company’s stock valued at $36,000 after acquiring an additional 248 shares during the period. Commonwealth Equity Services LLC lifted its stake in shares of Acadia Healthcare by 3.5% during the 2nd quarter. Commonwealth Equity Services LLC now owns 7,595 shares of the company’s stock worth $513,000 after purchasing an additional 257 shares during the last quarter. Atria Investments Inc boosted its position in Acadia Healthcare by 4.7% during the third quarter. Atria Investments Inc now owns 6,844 shares of the company’s stock valued at $434,000 after purchasing an additional 308 shares in the last quarter. Finally, KBC Group NV grew its stake in Acadia Healthcare by 14.4% in the third quarter. KBC Group NV now owns 2,688 shares of the company’s stock valued at $170,000 after purchasing an additional 338 shares during the last quarter.

Acadia Healthcare Price Performance

Shares of NASDAQ:ACHC opened at $37.82 on Friday. The company has a current ratio of 1.07, a quick ratio of 1.07 and a debt-to-equity ratio of 0.60. Acadia Healthcare Company, Inc. has a twelve month low of $37.78 and a twelve month high of $87.77. The company’s 50 day moving average is $58.05 and its 200 day moving average is $65.60. The company has a market cap of $3.51 billion, a PE ratio of 12.40, a price-to-earnings-growth ratio of 1.76 and a beta of 1.33.

Acadia Healthcare (NASDAQ:ACHC) last issued its earnings results on Wednesday, October 30th. The company reported $0.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.90 by $0.01. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The firm had revenue of $815.60 million during the quarter, compared to analysts’ expectations of $819.42 million. During the same quarter last year, the company posted $0.91 earnings per share. The firm’s revenue was up 8.7% compared to the same quarter last year. On average, sell-side analysts forecast that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on the stock. Cantor Fitzgerald restated a “neutral” rating and issued a $90.00 price target on shares of Acadia Healthcare in a report on Tuesday, October 1st. KeyCorp assumed coverage on shares of Acadia Healthcare in a research note on Friday, October 11th. They issued a “sector weight” rating for the company. Barclays decreased their price objective on Acadia Healthcare from $83.00 to $76.00 and set an “overweight” rating for the company in a report on Monday, September 30th. StockNews.com raised Acadia Healthcare from a “sell” rating to a “hold” rating in a research report on Thursday. Finally, Deutsche Bank Aktiengesellschaft boosted their price target on Acadia Healthcare from $70.00 to $75.00 and gave the stock a “hold” rating in a research note on Friday, August 2nd. Five investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $86.67.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.